Starting in January, Californians will be able to buy discounted insulin from the state. That’s thanks to CalRx, the state-run drug label created in 2020 that partners with manufacturers to slash generic prescription drug prices. CalRx already offers the opioid overdose reversal drug naloxone for about half the market price and other medications, including asthma inhalers, could be next. We’ll talk about whether this effort could ease the prescription drug affordability crisis and bolster the supply of crucial medications.

Guests:

April Dembosky, health correspondent, KQED News

Dr. Mariana Socal, associate professor of health policy, Johns Hopkins Bloomberg School of Public

Learn more about your ad choices. Visit megaphone.fm/adchoices